全文获取类型
收费全文 | 15680篇 |
免费 | 31篇 |
国内免费 | 67篇 |
专业分类
系统科学 | 71篇 |
丛书文集 | 258篇 |
教育与普及 | 43篇 |
理论与方法论 | 68篇 |
现状及发展 | 7507篇 |
研究方法 | 682篇 |
综合类 | 6951篇 |
自然研究 | 198篇 |
出版年
2013年 | 114篇 |
2012年 | 222篇 |
2011年 | 423篇 |
2010年 | 91篇 |
2008年 | 276篇 |
2007年 | 316篇 |
2006年 | 301篇 |
2005年 | 307篇 |
2004年 | 278篇 |
2003年 | 264篇 |
2002年 | 298篇 |
2001年 | 405篇 |
2000年 | 431篇 |
1999年 | 271篇 |
1992年 | 255篇 |
1991年 | 207篇 |
1990年 | 214篇 |
1989年 | 210篇 |
1988年 | 209篇 |
1987年 | 218篇 |
1986年 | 227篇 |
1985年 | 340篇 |
1984年 | 208篇 |
1983年 | 194篇 |
1982年 | 150篇 |
1981年 | 168篇 |
1980年 | 208篇 |
1979年 | 496篇 |
1978年 | 391篇 |
1977年 | 415篇 |
1976年 | 325篇 |
1975年 | 348篇 |
1974年 | 462篇 |
1973年 | 372篇 |
1972年 | 394篇 |
1971年 | 446篇 |
1970年 | 618篇 |
1969年 | 500篇 |
1968年 | 492篇 |
1967年 | 481篇 |
1966年 | 404篇 |
1965年 | 291篇 |
1964年 | 111篇 |
1959年 | 183篇 |
1958年 | 287篇 |
1957年 | 238篇 |
1956年 | 208篇 |
1955年 | 178篇 |
1954年 | 179篇 |
1948年 | 141篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
981.
982.
983.
Molecular mechanism for duplication 17p11.2- the homologous recombination reciprocal of the Smith-Magenis microdeletion 总被引:17,自引:0,他引:17
Potocki L Chen KS Park SS Osterholm DE Withers MA Kimonis V Summers AM Meschino WS Anyane-Yeboa K Kashork CD Shaffer LG Lupski JR 《Nature genetics》2000,24(1):84-87
Recombination between repeated sequences at various loci of the human genome are known to give rise to DNA rearrangements associated with many genetic disorders. Perhaps the most extensively characterized genomic region prone to rearrangement is 17p12, which is associated with the peripheral neuropathies, hereditary neuropathy with liability to pressure palsies (HNPP) and Charcot-Marie-Tooth disease type 1A (CMT1A;ref. 2). Homologous recombination between 24-kb flanking repeats, termed CMT1A-REPs, results in a 1.5-Mb deletion that is associated with HNPP, and the reciprocal duplication product is associated with CMT1A (ref. 2). Smith-Magenis syndrome (SMS) is a multiple congenital anomalies, mental retardation syndrome associated with a chromosome 17 microdeletion, del(17)(p11.2p11.2) (ref. 3,4). Most patients (>90%) carry deletions of the same genetic markers and define a common deletion. We report seven unrelated patients with de novo duplications of the same region deleted in SMS. A unique junction fragment, of the same apparent size, was identified in each patient by pulsed field gel electrophoresis (PFGE). Further molecular analyses suggest that the de novo17p11.2 duplication is preferentially paternal in origin, arises from unequal crossing over due to homologous recombination between flanking repeat gene clusters and probably represents the reciprocal recombination product of the SMS deletion. The clinical phenotype resulting from duplication [dup(17)(p11.2p11.2)] is milder than that associated with deficiency of this genomic region. This mechanism of reciprocal deletion and duplication via homologous recombination may not only pertain to the 17p11.2 region, but may also be common to other regions of the genome where interstitial microdeletion syndromes have been defined. 相似文献
984.
MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability 总被引:24,自引:0,他引:24
Lipkin SM Wang V Jacoby R Banerjee-Basu S Baxevanis AD Lynch HT Elliott RM Collins FS 《Nature genetics》2000,24(1):27-35
DNA mismatch repair is important because of its role in maintaining genomic integrity and its association with hereditary non-polyposis colon cancer (HNPCC). To identify new human mismatch repair proteins, we probed nuclear extracts with the conserved carboxy-terminal MLH1 interaction domain. Here we describe the cloning and complete genomic sequence of MLH3, which encodes a new DNA mismatch repair protein that interacts with MLH1. MLH3 is more similar to mismatch repair proteins from yeast, plants, worms and bacteria than to any known mammalian protein, suggesting that its conserved sequence may confer unique functions in mice and humans. Cells in culture stably expressing a dominant-negative MLH3 protein exhibit microsatellite instability. Mlh3 is highly expressed in gastrointestinal epithelium and physically maps to the mouse complex trait locus colon cancer susceptibility I (Ccs1). Although we were unable to identify a mutation in the protein-coding region of Mlh3 in the susceptible mouse strain, colon tumours from congenic Ccs1 mice exhibit microsatellite instability. Functional redundancy among Mlh3, Pms1 and Pms2 may explain why neither Pms1 nor Pms2 mutant mice develop colon cancer, and why PMS1 and PMS2 mutations are only rarely found in HNPCC families. 相似文献
985.
Ross DT Scherf U Eisen MB Perou CM Rees C Spellman P Iyer V Jeffrey SS Van de Rijn M Waltham M Pergamenschikov A Lee JC Lashkari D Shalon D Myers TG Weinstein JN Botstein D Brown PO 《Nature genetics》2000,24(3):227-235
We used cDNA microarrays to explore the variation in expression of approximately 8,000 unique genes among the 60 cell lines used in the National Cancer Institute's screen for anti-cancer drugs. Classification of the cell lines based solely on the observed patterns of gene expression revealed a correspondence to the ostensible origins of the tumours from which the cell lines were derived. The consistent relationship between the gene expression patterns and the tissue of origin allowed us to recognize outliers whose previous classification appeared incorrect. Specific features of the gene expression patterns appeared to be related to physiological properties of the cell lines, such as their doubling time in culture, drug metabolism or the interferon response. Comparison of gene expression patterns in the cell lines to those observed in normal breast tissue or in breast tumour specimens revealed features of the expression patterns in the tumours that had recognizable counterparts in specific cell lines, reflecting the tumour, stromal and inflammatory components of the tumour tissue. These results provided a novel molecular characterization of this important group of human cell lines and their relationships to tumours in vivo. 相似文献
986.
987.
Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome 总被引:19,自引:0,他引:19
Ménasché G Pastural E Feldmann J Certain S Ersoy F Dupuis S Wulffraat N Bianchi D Fischer A Le Deist F de Saint Basile G 《Nature genetics》2000,25(2):173-176
Griscelli syndrome (GS, MIM 214450), a rare, autosomal recessive disorder, results in pigmentary dilution of the skin and the hair, the presence of large clumps of pigment in hair shafts and an accumulation of melanosomes in melanocytes. Most patients also develop an uncontrolled T-lymphocyte and macrophage activation syndrome (known as haemophagocytic syndrome, HS), leading to death in the absence of bone-marrow transplantation. In contrast, early in life some GS patients show a severe neurological impairment without apparent immune abnormalities. We previously mapped the GS locus to chromosome 15q21 and found a mutation in a gene (MYO5A) encoding a molecular motor in two patients. Further linkage analysis suggested a second gene associated with GS was in the same chromosomal region. Homozygosity mapping in additional families narrowed the candidate region to a 3.1-cM interval between D15S1003 and D15S962. We detected mutations in RAB27A, which lies within this interval, in 16 patients with GS. Unlike MYO5A, the GTP-binding protein RAB27A appears to be involved in the control of the immune system, as all patients with RAB27A mutations, but none with the MYO5A mutation, developed HS. In addition, RAB27A-deficient T cells exhibited reduced cytotoxicity and cytolytic granule exocytosis, whereas MYO5A-defective T cells did not. RAB27A appears to be a key effector of cytotoxic granule exocytosis, a pathway essential for immune homeostasis. 相似文献
988.
989.
Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector 总被引:24,自引:0,他引:24
Kay MA Manno CS Ragni MV Larson PJ Couto LB McClelland A Glader B Chew AJ Tai SJ Herzog RW Arruda V Johnson F Scallan C Skarsgard E Flake AW High KA 《Nature genetics》2000,24(3):257-261
Pre-clinical studies in mice and haemophilic dogs have shown that introduction of an adeno-associated viral (AAV) vector encoding blood coagulation factor IX (FIX) into skeletal muscle results in sustained expression of F.IX at levels sufficient to correct the haemophilic phenotype. On the basis of these data and additional pre-clinical studies demonstrating an absence of vector-related toxicity, we initiated a clinical study of intramuscular injection of an AAV vector expressing human F.IX in adults with severe haemophilia B. The study has a dose-escalation design, and all patients have now been enrolled in the initial dose cohort (2 x 10(11) vg/kg). Assessment in the first three patients of safety and gene transfer and expression show no evidence of germline transmission of vector sequences or formation of inhibitory antibodies against F.IX. We found that the vector sequences are present in muscle by PCR and Southern-blot analyses of muscle biopsies and we demonstrated expression of F.IX by immunohistochemistry. We observed modest changes in clinical endpoints including circulating levels of F.IX and frequency of FIX protein infusion. The evidence of gene expression at low doses of vector suggests that dose calculations based on animal data may have overestimated the amount of vector required to achieve therapeutic levels in humans, and that the approach offers the possibility of converting severe haemophilia B to a milder form of the disease. 相似文献
990.